S101 autologous anti-CD7 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S101 autologous anti-CD7 CAR-T cells, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL. [Phase 2]